Page last updated: 2024-10-25

cimetidine and Urethral Obstruction

cimetidine has been researched along with Urethral Obstruction in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Urethral Obstruction: Partial or complete blockage in any part of the URETHRA that can lead to difficulty or inability to empty the URINARY BLADDER. It is characterized by an enlarged, often damaged, bladder with frequent urges to void.

Research Excerpts

ExcerptRelevanceReference
"Cimetidine was found to be no more active than vitamin C in treating benign prostatic hypertrophy."2.67Controlled study of cimetidine in the treatment of benign prostatic hypertrophy. ( Brooks, ME; Lindner, A; Ramon, J, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindner, A1
Ramon, J1
Brooks, ME1

Trials

1 trial available for cimetidine and Urethral Obstruction

ArticleYear
Controlled study of cimetidine in the treatment of benign prostatic hypertrophy.
    British journal of urology, 1990, Volume: 66, Issue:1

    Topics: Adult; Aged; Cimetidine; Double-Blind Method; Humans; Male; Middle Aged; Prostatic Hyperplasia; Rand

1990